Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).

[1]  D. Petitti.  Combination Estrogen–Progestin Oral Contraceptives , 2003 .

[2]  A. Fisher,et al.  Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol. , 2003, Contraception.

[3]  J. Jensen,et al.  Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. , 2003, Contraception.

[4]  C. Gerlinger,et al.  Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel , 2001 .

[5]  L. Shulman,et al.  Current perspectives on oral contraceptive use. , 2001, American journal of obstetrics and gynecology.

[6]  J. Herman,et al.  Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals. , 2001, Regulatory toxicology and pharmacology : RTP.

[7]  M. Rosenberg,et al.  Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparations , 1999 .

[8]  D. Archer,et al.  Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®) , 1999 .

[9]  I. den Tonkelaar,et al.  Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. , 1999, Contraception.

[10]  J. Massaro,et al.  Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction. , 1999, Contraception.

[11]  J. Rowan.  "Estrophasic" dosing: A new concept in oral contraceptive therapy. , 1999, American journal of obstetrics and gynecology.

[12]  M. Dolker,et al.  International clinical experience with a new low-dose, Monophasic oral contraceptive containing levonorgestrel 100 μg and ethinyl estradiol 20 μg , 1999 .

[13]  M. Rosenberg,et al.  Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. , 1998, American journal of obstetrics and gynecology.

[14]  D. Archer,et al.  A new low-dose monophasic combination oral contraceptive (Alesse™) with levonorgestrel 100 μg and ethinyl estradiol 20 μg , 1997 .

[15]  D. Archer,et al.  A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG). , 1997, Contraception.

[16]  R. Dickey.  Managing Contraceptive Pill Patients , 1994 .